Supplementary Table 2.
Characteristics of COVID-19 Cases Presenting With and Without Symptoms (n = 76)
| COVID+ |
P Value | ||
|---|---|---|---|
| Symptomatic (n = 37) | Asymptomatic (n = 39) | ||
| Sex, male, n (%) | 9 (24.3) | 12 (30.8) | .53 |
| Age, y, mean ± SD | 84.9 ± 7.8 | 85.7 ± 6.9 | .67 |
| CIRS-comorbidity index, median (IQR) | 5 (4, 7) | 5 (4, 6) | .27 |
| CIRS-severity index, median (IQR) | 2.1 (1.9, 2.4) | 2.1 (1.9, 2.3) | .42 |
| Number of drugs, median (IQR) | 8 (5, 10) | 7 (5, 9) | .32 |
| MMSE, mean ± SD | 15.8 ± 7.0 | 15.3 ± 7.7 | .76 |
| Vaccinated for influenza, n (%) | 26 (70.3) | 33 (84.6) | .13 |
| Chronic diseases (moderate severity according to CIRS), n (%) | |||
| Cardiac | 41 (54.0) | 31 (40.8) | .13 |
| Hypertension | 32 (42.1) | 35 (46.1) | .65 |
| Vascular/hematologic | 36 (47.4) | 34 (44.7) | .75 |
| Respiratory | 15 (19.7) | 18 (23.7) | .55 |
| Ophthalmologic and otorhinolaryngologic | 19 (38.2) | 17 (22.4) | .03 |
| Upper gastrointestinal | 30 (39.5) | 47 (61.8) | .01 |
| Lower gastrointestinal | 26 (34.2) | 26 (34.2) | 1.00 |
| Hepatic and pancreatic | 4 (5.3) | 5 (6.6) | .74 |
| Renal | 6 (7.9) | 4 (5.3) | .53 |
| Genitourinary | 53 (69.7) | 60 (79.0) | .21 |
| Musculoskeletal and dermatologic | 48 (63.2) | 60 (79.0) | .04 |
| Neurologic (excluding dementia) | 36 (47.4) | 37 (48.7) | .87 |
| Endocrine – metabolic | 30 (39.5) | 31 (40.8) | .85 |
| Psychiatric/behavioral | 71 (93.4) | 70 (92.1) | .76 |
| Frailty (Frail-NH score >7), n (%) | 27 (73.0) | 20 (51.3) | .05 |
| Frailty, n (%) | .06 | ||
| Non-frail (Frail-NH score 0–1) | 2 (5.4) | 6 (15.4) | |
| Mild or moderate frailty (Frail-NH score 2–5) | 4 (10.8) | 10 (25.6) | |
| Most frail (Frail-NH score 6–14) | 31 (83.8) | 23 (59.0) | |
CIRS, cumulative illness rating scale; IQR, interquartile range; SD, standard deviation.